Clinical Trials Directory

Trials / Completed

CompletedNCT00645125

A Comparative, Single-Center, Pediatric Taste Test Study of Omnicef Versus Amoxicillin Antibiotic Suspension Medications

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
154 (actual)
Sponsor
Abbott · Industry
Sex
All
Age
4 Years – 8 Years
Healthy volunteers
Accepted

Summary

To compare the taste and smell acceptability scores of cefdinir (Omnicef) versus amoxicillin oral antibiotic suspension medications in pediatric subjects. It is designed to determine if Omnicef or amoxicillin is preferred to the other with regard to taste or smell.

Detailed description

The Primary Purpose for the study is "Other". Per ClinicalTrials.gov, more information regarding the primary purpose is described here; the primary purpose for the study is to determine whether cefdinir possesses preferred taste and smell characteristics when compared to amoxicillin, a pediatric taste test.

Conditions

Interventions

TypeNameDescription
DRUGcefdinir (Omnicef)2.5 ml of strawberry cream flavored oral suspension 125 mg/5 mL
DRUGamoxicillin2.5 ml of bubble-gum flavored amoxicillin oral suspension 125 mg/5 mL

Timeline

Start date
2003-01-01
Primary completion
2003-02-01
First posted
2008-03-27
Last updated
2008-03-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00645125. Inclusion in this directory is not an endorsement.